Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor

Annals of Internal Medicine

Volumn 143, Issue 9, 2005, Pages

  Tugwell, Barna D ^a   Patel, Priti R ^b   Williams, Ian T ^b   Hedberg, Katrina ^b   Chai, Feng ^b   Nainan, Omana V ^b   Thomas, Ann R ^b   Woll, Judith E ^b   Bell, Beth P ^b   Cieslak, Paul R ^b  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ACUTE HEPATITIS; ADULT; ARTICLE; BONE GRAFT; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; DONOR; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; MALE; MOLECULAR PHYLOGENY; NONHUMAN; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; SCREENING TEST; SERUM; SKIN GRAFT; TENDON GRAFT; TISSUE TRANSPLANTATION; VIREMIA; VIRUS ISOLATION; VIRUS TRANSMISSION;

EID: 27644534847     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-143-9-200511010-00008     Document Type: Article

References (31)

1. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556-62. [PMID: 10451460]
2. Pereira BJ, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med. 1991;325:454-60. [PMID: 1649402]
3. Pereira BJ, Milford EL, Kirkman RL, Quan S, Sayre KR, Johnson PJ, et al. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med. 1992;327:910-5. [PMID: 1325035]
4. Roth D, Fernandez JA, Babischkin S, De Mattos A, Buck BE, Quan S, et al. Detection of hepatitis C virus infection among cadaver organ donots: evidence for low transmission of disease. Ann Intern Med. 1992;117:470-5. [PMID: 1323944]
5. Aeder MI, Shield CF, Tegtmeier GE, Bayer W, Luger AM, Nelson PW, et al. Incidence and clinical impact of hepatitis C virus-positive donors in cadaveric transplantation. Transplant Proc. 1993;25:1469-71. [PMID: 7680164]
6. Tesi RJ, Waller K, Morgan CJ, Delaney S, Elkhammas EA, Henry ML, et al. Transmission of hepatitis C by kidney transplantation-the risks. Transplantation. 1994;57:826-31. [PMID: 8154029]
7. Aswad S, Obispo E, Mendez RG, Mendez R. HCV+ donors: should they be used for organ transplantation? Transplant Proc. 1993;25:3072-4. [PMID: 8266457]
8. Pereira BJ, Wright TL, Schmid CH, Bryan CF, Cheung RC, Cooper ES, et al. Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: a U.S. National Collaborative Study. Kidney Int. 1994;46:886-92. [PMID: 7527878]
9. Huang CC, Lai MK, Lin MW, Pao CC, Fang JT, Yao DS. Transmission of hepatitis C virus by renal transplantation. Transplant Proc 1993;25:1474-5. [PMID: 7680165]
10. Pereira BJ, Milford EL, Kirkman RL, Levey AS, Tomford WW, Leibowitz H, et al. Low risk of liver disease after tissue transplantation from donors with HCV [Letter]. Lancet. 1993;341:903-4. [PMID: 7681921]
11. Eggen BM, Nordbo SA. Transmission of HCV by organ transplantation [Letter]. N Engl J Med. 1992;326:411; author reply 412-3. [PMID: 1309597]
12. Conrad EU, Gretch DR, Obermeyer KR, Moogk MS, Sayers M, Wilson JJ, et al. Transmission of the hepatitis-C virus by tissue transplantation. J Bone Joint Surg Am. 1995;77:214-24. [PMID: 7844127]
13. U.S. Census Bureau. Table 164: organ transplants and grafts: 1990 to 2003. In: Statistical Abstract of the United States: 2004-2005. Washington, DC: U.S.
14. Census Bureau; 2004. Accessed at www.census.gov/prod/2004pubs/04statab/ health.pdf on 28 April 2005.
15. Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products. Final rule. Fed Regist. 2004;69:29785-834. Accessed at www.fda.gov/cber/rules/suitdonor.pdf on 28 April 2005. [PMID: 15160713]
16. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR Recomm Rep. 1991;40:1-17. [PMID: 1850496]
17. U.S. Food and Drug Administration Center for Biologics Evaluation and Research. Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). Washington, DC: U.S. Department of Health and Human Services; 2004. Accessed at www.fda.gov/cber/gdlns/tissdonor.pdf on 28 April 2005.
18. Current good tissue practice for human cell, tissue, and cellular and tissue-based product establishments; inspection and enforcement. Final rule. Fed Regist. 2004;69:68611-88. Accessed at www.fda.gov/cber/rules/gtp.pdf on 28 April 2005. [PMID: 15562555]
19. Cody SH, Nainan OV, Garfein RS, Meyers H, Bell BP, Shapiro CN, et al. Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med. 2002;162:345-50. [PMID: 11822928]
20. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993;74(Pt 11):2391-9. [PMID: 8245854]
21. Enomoto N, Takada A, Nakao T, Date T. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun. 1990;170:1021-5. [PMID: 2117923]
22. Devereux J, Haeberli P, Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 1984;12:387-95. [PMID: 6546423]
23. Felsenstein J. Confidence limits on phytogenies: an approach using the bootstrap. Evolution. 1985;39:783-91.
24. Busch MP, Meinman SH, Jackson B, Stramer SL, Hewlett I, Preston S. Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. Transfusion. 2000;40:143-59. [PMID: 10685998]
25. U.S. Food and Drug Administration Center for Biologies Evaluation and Research. Tissue related product approvals. Accessed at www.fda.gov/cber/tissue /prod.htm on 28 April 2005.
26. Zou S, Dodd RY, Stramer SL, Strong DM. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med. 2004;351:751-9. [PMID: 15317888]
27. Stramer SL, Glynn SA, Meinman SH, Strong DM, Sally C, Wright DJ, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med. 2004;351:760-8. [PMID: 15317889]
28. Tomford WW. Transmission of disease through transplantation of musculoskeletal allografts. J Bone Joint Surg Am. 1995;77:1742-54. [PMID: 7593087]
29. Pelker RR, Friedlaender GE. Biomechanical aspects of bone autografts and allografts. Orthop Clin North Am. 1987;18:235-9. [PMID: 3561975]
30. Kainer MA, Linden JV, Whaley DN, Holmes HT, Jarvis WR, Jernigan DB, et al. Clostridium infections associated with musculoskeletal-tissue allografts. N Engl J Med. 2004;350:2564-71. [PMID: 15201413]
31. Human cells, tissues, and cellular and tissue-based products; establishment registration and listing. Food and Drug Administration, HHS. Final rule. Fed Regist. 2001;66:5447-69. Accessed at www.fda.gov/cber/rules/ frtisreg011901.pdf on 1 May 2005. [PMID: 11503777]